Literature DB >> 1731727

Microbial contamination of in-use ocular medications.

O D Schein1, P L Hibberd, T Starck, A S Baker, K R Kenyon.   

Abstract

Two hundred twenty in-use medications from 101 patients with nonmicrobial ocular surface disease were studied by culturing the bottle caps, a drop produced by simple inversion, and the interior contents removed sterilely. Conjunctival cultures were taken from these patients and 50 age-matched controls. Pathogenic organisms were harvested from conjunctivae significantly more frequently (P less than .01) from cases (34 of 101) than from controls (five of 50). Sixty-four medications (29%) had microorganisms cultured from at least one medication site. Gram-negative organisms were significantly more likely (P less than .00001) to be isolated from all medication sites than gram-positive organisms. Additionally, when isolated from medication sites, the gram-negative organisms were highly likely to be cultured from the conjunctiva as well. This was not true for pathogenic gram-positive organisms. We conclude that a cycle of contamination between in-use medications and conjunctivae may represent an important risk factor for microbial keratitis in patients with ocular surface disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731727     DOI: 10.1001/archopht.1992.01080130084030

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  21 in total

1.  Cytoprotective effect of hyaluronic acid and hydroxypropyl methylcellulose against DNA damage induced by thimerosal in Chang conjunctival cells.

Authors:  Juan Ye; Huina Zhang; Han Wu; Changjun Wang; Xin Shi; Jiajun Xie; Jinjing He; Jun Yang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-24       Impact factor: 3.117

2.  Microbial contamination of multi-use ophthalmic solutions in Kenya.

Authors:  M M Nentwich; K H M Kollmann; J Meshack; D R Ilako; U C Schaller
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

3.  Irreversible electroporation for microbial control of drugs in solution.

Authors:  Alex Golberg; Michael Belkin; Boris Rubinsky
Journal:  AAPS PharmSciTech       Date:  2009-07-02       Impact factor: 3.246

4.  To preserve or not to preserve, is that the question?

Authors:  L A Wilson
Journal:  Br J Ophthalmol       Date:  1996-07       Impact factor: 4.638

5.  Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives.

Authors:  Elmer Y Tu
Journal:  Saudi J Ophthalmol       Date:  2014-06-23

6.  Microbial contamination of preservative free eye drops in multiple application containers.

Authors:  M Q Rahman; D Tejwani; J A Wilson; I Butcher; K Ramaesh
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

7.  Predictive factors for response to medical therapy in bacterial ulcerative keratitis.

Authors:  R Y Kim; K L Cooper; L D Kelly
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-12       Impact factor: 3.117

8.  Bacterial contamination of ophthalmic solutions used in an extended care facility.

Authors:  Danny H-Kauffmann Jokl; Gary P Wormser; Neil S Nichols; Marisa A Montecalvo; Carol L Karmen
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

9.  An evaluation of how glaucoma patients use topical medications: a pilot study.

Authors:  Tony Tsai; Alan L Robin; Judson P Smith
Journal:  Trans Am Ophthalmol Soc       Date:  2007

10.  Microbial contamination of medications used to treat glaucoma.

Authors:  O Geyer; E J Bottone; S M Podos; R A Schumer; P A Asbell
Journal:  Br J Ophthalmol       Date:  1995-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.